AVTR
Avantor Inc
NYSE: AVTR · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$7.85
-0.13% today
Updated 2026-04-29
Market cap
$5.35B
P/E ratio
—
P/S ratio
0.82x
EPS (TTM)
$-0.78
Dividend yield
—
52W range
$7 – $16
Volume
9.3M
Avantor Inc (AVTR) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$7.85
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$25.68
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $7.4B | $4.9B | $7.0B | $6.8B | $6.6B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -8.09%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.